Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 1;14(4):712-715.
doi: 10.21037/hbsn-2025-352. Epub 2025 Jul 24.

Call a spade a spade

Elke Roeb  1
Affiliations
Editorial

Call a spade a spade

Elke Roeb. Hepatobiliary Surg Nutr. .
No abstract available

Keywords: Metabolic dysfunction-associated steatotic liver disease (MASLD); chronic kidney disease (CKD); metabolic dysfunction-associated fatty liver disease (MAFLD); non-alcoholic fatty liver disease (NAFLD); steatosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://hbsn.amegroups.com/article/view/10.21037/hbsn-2025-352/coif). The author reports a grant from German Research Foundation (DFG; grants DFG AZ RO957/13-1) and she is a speaker for Abbvie, Falk Foundation, BMS, Gilead, Intercept, and Norgine; and has received consultancy fees from Alexion, Boehringer Ingelheim, Gsk, Ipsen, Merz, Pfizer, Takeda, and Xcenda. The author has no other conflicts of interest to declare.

Comment on

References

    1. Roeb E, Canbay A, Bantel H, et al. Amendment "New nomenclature for MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)" to the S2k guideline "Non-alcoholic fatty liver disease" (v.2.0/April 2022) of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS). Z Gastroenterol 2024;62:2065-74. 10.1055/a-2408-3429 - DOI - PubMed
    1. Roeb E, Geier A. Nonalcoholic steatohepatitis (NASH) - current treatment recommendations and future developments. Z Gastroenterol 2019;57:508-17. 10.1055/a-0784-8827 - DOI - PubMed
    1. Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 2020;73:202-9. 10.1016/j.jhep.2020.03.039 - DOI - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol 2023;79:1542-56. 10.1016/j.jhep.2023.06.003 - DOI - PubMed
    1. Roeb E, Canbay A, Bantel H, et al. Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) - April 2022 - AWMF Registration No.: 021-025. Z Gastroenterol 2022;60:e733-801. 10.1055/a-1880-2388 - DOI - PubMed

LinkOut - more resources